A Real World Evidence prospective cohort study in the management of metastatic colorectal cancer: a clinical and patient perspective (PROMETCO)

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Effectiveness study (incl. comparative)

  Other
• If ‘other’, further details on the scope of the study:
  Overall survival in real world setting

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Medical condition to be studied:
  Colorectal cancer metastatic

Population studied

• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  1000

Study design details

• Main study objective:
  To describe the following for mCRC patients in a real world setting:- Overall survival- Treatment patterns for mCRC throughout the continuum of care- Effectiveness/safety of treatments- Reasons for therapy discontinuations and choice of subsequent treatment- Adherence to National and European Guidelines- Healthcare resource utilization- Patient reported outcomes
• Data analysis plan:
  descriptive statistics